HF10 Therapy - High Frequency Stimulation
Do you have chronic low back and/or leg pain? Do you feel like you’ve tried everything and nothing has seemed to work? Did you try Spinal Cord Stimulation (SCS) only to have that fail as well?
The doctors at the Ainsworth Institute are proud to now offer HF10 Therapy!
We are now offering a brand new treatment option shown in clinical studies to reduce back pain by 66.4% and leg pain by 69.5% at 12 months. 
Nevro and the Ainsworth Institute present the Senza – the only device FDA-approved for High Frequency Stimulation in the United States
What is HF10 Therapy?
The “HF” in HF10 stands for high frequency and “10” refers to 10,000 Hertz. This revolutionary treatment uses a high frequency current at 10kHz to stop pain in its tracks.
HF10 Therapy is a type of spinal cord stimulation (SCS), with one very important difference – the frequency used on the nervous system is so much higher that there is no sensation felt from the stimulator and significantly more pain is blocked. The FDA clinical trial (Senza Study) showed that patients treated with HF10 therapy had better pain relief, improved function and higher satisfaction scores. 
HF10 Therapy was approved by the FDA in 2015, however it has been available in the Europe and Australia for nearly a decade. Before it’s release, patients were traveling to other continents to receive this amazing treatment.
Is HF10 Therapy Better than Traditional SCS?
HF10 Therapy is a type of SCS shown to be superior to conventional SCS in every study and clinical trial conducted. While the utility of SCS remains unquestioned, it doesn’t always help everyone. Generally speaking, as little as 50% of patients will report significant pain relief from SCS. Also, there are a laundry list of other deficiencies with traditional SCS: as many as 40% of implanted patients report unsatisfactory pain relief, positional-related changes in the perception of neurostimulation,i above decreased pain relief over time despite appropriate coverage,. the inability to consistently capture certain body parts like the back and the foot,, and paresthesias in unwanted areas of the body.
This led scientists to search for ways to improve this treatment and provide more relief to more patients. In 2009, the United States Feasibility study was performed – 88% of patients preferred HF10 to traditional SCS with reports of 76.6% reduction in overall pain. In 2014, the Senza Study (U.S. Pivotal Study was performed with 241 patients enrolled. The results were astounding – 83.1% of reported significant pain relief, whereas only 43.8% of patients receiving traditional SCS for low back pain and 55.5% with leg pain reported significant relief. Most importantly, HF10 was shown to be superior at 1-year to traditional SCS. 
Significantly greater pain relief than SCS
No paresthesias (buzzing sensation)
Consistent pain relief for the low back
If you’re considering getting a Spinal Cord Stimulator trial, find out if you’re a candidate for HF10 Therapy first! If you suffer from chronic low back and/or leg pain, give yourself the best chance at relief. Contact the Ainsworth Institute of Pain Management to to see if this amazing technologic advancement is right for you.
 Kapural et al. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial. Anesthesiology 2015;123:851-80.
 North RB. Neural intervace devices: spinal cord stimulation technology. Proc IEEE 2008;96:1108-1119.
 Turner JA, Loeser JD, Deyo RA, Sanders SB. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a systemic review of effectiveness and complications. Pain 2004;108:137-147.
 Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg 2004;100:254-267.
 Hunter C, Davé N, Diwan S, Deer T. Neuromodulation of Pelvic Visceral Pain: A Review of the Literature and Case Series of Potential Novel Targets for Treatment. Pain Practice 2013;13:3-17.
 Deer TR, Grigsby E, Weiner RL, Wilcosky B, Kramer JM. A prospective study of dorsal root ganglion stimulation for the relief of chronic pain. Neuromodulation 2013;16;67-72.
 Tiede et al. Novel spinal cord stimulation parameters in patients with predominant back pain. Neuromodulation 2013;16:370-5.